- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07596160
Individualized Exercise Consultation in Type 1 Diabetes (ACTIVE-T1D)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background Physical activity is a recommended and integral component of T1D treatment, as it confers a range of health benefits, including improved insulin sensitivity, better glycaemic regulation, enhanced cardiovascular fitness, healthier lipid profiles, weight management, reduced blood pressure, and a lower risk of diabetes-related complications (1). Additionally, regular exercise supports psychological well-being and overall quality of life for people living with type 1 diabetes (2). However, despite written guidelines on the topic (3), individuals with type 1 diabetes often experience challenges with blood glucose excursions before, during, and after exercise (4, 5), limiting participation in regular exercise.
In recognition of limited guidance for individuals with type 1 diabetes regarding exercise (6), the Clinic for Athletes with Type One Diabetes (CATOD) was established in 2019 at the Steno Diabetes Center Aarhus (SDCA). CATOD is the first clinic of its kind and has transformed care for individuals with type 1 diabetes who exercise. Initially, the clinic primarily supported highly active athletes with type 1 diabetes through sports camps followed by a 6-12 month consultation programme focused on exercise and diabetes management strategies(7).
Since 2023 the clinic has expanded to provide 1-3 videoconsultations to a broad range of individuals with type 1 diabetes across the nation in order to help them with exercise obstacles. The problems presented span from going for a walk or bicycling to work without getting a low blood glucose to how to manage glucose during marathon training and competition. During the consultations, the individual with type 1 diabetes receives individualized guidance on exercise, glucose management, insulin adjustment, and nutrition.
Evidence from a prior questionnaire administered to participants who received the intervention suggests that many benefited from the advice and were able to modify their exercise habits, facilitating more effective and less burdensome physical activity.
Aim This study aims to expand current knowledge on the effectiveness of individualized exercise consultations in people with type 1 diabetes. Specifically, we will evaluate whether individualized, video-based exercise consultations can improve physical activity levels, glycemic control and patient empowerment.
Objectives
To determine whether individualized, exercise-specific consultations:
- Increase physical activity levels
- Improve glycemic control during and around exercise, as well as overall glycemic control
- Enhance confidence and self-management related to exercise
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rakel F Johansen, MD, PhD
- Phone Number: +4540530612
- Email: rfjohansen@clin.au.dk
Study Contact Backup
- Name: Jesper F Mortensen, MSc
- Phone Number: +45 23234145
- Email: jfm@au.dk
Study Locations
-
-
-
Aarhus, Denmark, 8200
- Steno Diabetes Center Aarhus
-
Contact:
- Rakel F Johansen, MD Phd
- Phone Number: +4540530612
- Email: rfjohansen@clin.au.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of type 1 diabetes
- Age ≥18 years
- Willingness to participate
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise Consultations
|
Participants will receive individualized 30-minute video consultations concerning exercise and type 1 diabetes obstacles. During the consultations, individuals with type 1 diabetes are guided by a physician and, when relevant, an exercise physiologist from Steno Diabetes Center Aarhus (SDCA). The intervention will in most cases consist of two consultations, although an additional consultation may be offered if considered relevant. The first consultation is planned based on information about the individual's exercise habits and specific challenges. All consultations are conducted via video, allowing participants to receive tailored, practical advice adapted to their daily life and preferred physical activities. Consultations will address the topics that the patient presents, which may include, but is not limited to:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Eight Likert scale questions regarding the ability of the partipant to handle type 1 diabetes and exercise challenges. Assessed before the first consultation, right after the last consultation and 6 months after the last consultation
Time Frame: Six months
|
Six months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-20-72-8-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
Clinical Trials on Exercise consultations
-
Taipei Veterans General Hospital, TaiwanActive, not recruiting
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University of California, San FranciscoCompletedCareer Development Grant OutcomesUnited States
-
Manchester University NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedCrohn's Disease | Ulcerative ColitisUnited Kingdom
-
Odense University HospitalUniversity of Southern DenmarkCompletedQuality of Life | Reduction, HarmDenmark
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Janssen, LP; Dutch Cancer SocietyCompleted
-
University Hospital, Gentofte, CopenhagenSanofi; Aage Bangs Fond; The Novo Nordic Foundation; Herlev and Gentofte Hospital; Almirall, S.A...Active, not recruiting
-
Sheba Medical CenterCompletedObesity, ChildhoodIsrael
-
Johnny FroekjaerEuropean Commission; Region of Southern DenmarkUnknown
-
Ditte Krag-HansenAstraZeneca; Sygehus LillebaeltRecruitingCOPD | Lung Carcinoma | Pulmonary Neoplasms | Lung Neoplasm Malignant | Pulmonary Carcinoma | Pulmonary Cancer | Lung Cancer (Diagnosis) | Pulmonary Neoplasm | COPD (Chronic Obstructive Pulmonary Disease) | Airflow Obstruction, Chronic | COPD - Chronic Obstructive Pulmonary Disease | Pulmonary CancersDenmark